ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tonnesen, P
Right arrow Articles by Sawe, U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tonnesen, P
Right arrow Articles by Sawe, U
Eur Respir J 1999; 13: 238-246
Copyright © ERS Journals Ltd 1999

Clinical Trial

Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society

P Tonnesen, P Paoletti, G Gustavsson, MA Russell, R Saracci, A Gulsvik, B Rijcken, and U Sawe

The Collaborative European Anti-Smoking Evaluation (CEASE) was a European multicentre, randomized, double-blind placebo controlled smoking cessation study. The objectives were to determine whether higher dosage and longer duration of nicotine patch therapy would increase the success rate. Thirty-six chest clinics enrolled a total of 3,575 smokers. Subjects were allocated to one of five treatment arms: placebo and either standard or higher dose nicotine patches (15 mg and 25 mg daily) each given for 8 or 22 weeks with adjunctive moderately intensive support. The 12 month sustained success rates were: 25 mg patch for 22 weeks (L-25), 15.4%; 25 mg patch for 8 weeks (S-25), 15.9%; 15 mg patch for 22 weeks (L-15), 13.7%; 15 mg patch for 8 weeks (S-15), 11.7%; and placebo (P-0) 9.9% (placebo versus 15 mg, p<0.05; 25 mg versus 15 mg, p<0.03; 25 mg versus placebo, p<0.001, Chi-squared test). There was no significant difference in success rate between the two active treatment durations. Of the first week abstainers (n=1,698), 25.1% achieved success at 12 months as opposed to first week smokers, 2.7% of 1,877 subjects (p< 0.001). In summary, a higher than standard dose of nicotine patch was associated with an increase in the long-term success in smoking cessation but continuation of treatment beyond 8-12 weeks did not increase the success rates.


This article has been cited by other articles:


Home page
 CA Cancer J ClinHome page
R. D. Hurt, J. O. Ebbert, J. T. Hays, and D. D. McFadden
Treating Tobacco Dependence in a Medical Setting
CA Cancer J Clin, September 1, 2009; 59(5): 314 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Nicotine Tob ResHome page
D. J. Ossip, S. M. Abrams, M. C. Mahoney, D. Sall, and K. M. Cummings
Adverse effects with use of nicotine replacement therapy among quitline clients
Nicotine Tob Res, April 1, 2009; 11(4): 408 - 417.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
K. O. Fagerstrom and C. A. Jimenez-Ruiz
Pharmacological treatments for tobacco dependence
Eur. Respir. Rev., December 1, 2008; 17(110): 192 - 198.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
M. J. Eisenberg MD MPH, K. B. Filion MSc, D. Yavin BSc, P. Belisle MSc, S. Mottillo BSc, L. Joseph PhD, A. Gervais MD, J. O'Loughlin PhD, G. Paradis MD MSc, S. Rinfret MD MSc, et al.
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials
Can. Med. Assoc. J., July 15, 2008; 179(2): 135 - 144.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
S. K. Myung, K.-Y. Yoo, S. W. Oh, S. H. Park, H. G. Seo, S. S. Hwang, and S. K. Park
Meta-analysis of studies investigating one-year effectiveness of transdermal nicotine patches for smoking cessation
Am. J. Health Syst. Pharm., December 1, 2007; 64(23): 2471 - 2476.
[Abstract] [Full Text] [PDF]

Home page
 Tobacco ControlHome page
R A Walsh, L. Stead, and T. Lancaster
The Cochrane review on nicotine replacement therapy: incorrect or uncertain classifications of additional support levels * Authors' response
Tob. Control, June 1, 2007; 16(3): 215 - 216.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Tonnesen, L. Carrozzi, K. O. Fagerstrom, C. Gratziou, C. Jimenez-Ruiz, S. Nardini, G. Viegi, C. Lazzaro, I. A. Campell, E. Dagli, et al.
Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
Eur. Respir. J., February 1, 2007; 29(2): 390 - 417.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M Bednarek, D Gorecka, J Wielgomas, M Czajkowska-Malinowska, J Regula, G Mieszko-Filipczyk, M Jasionowicz, R Bijata-Bronisz, M Lempicka-Jastrzebska, M Czajkowski, et al.
Smokers with airway obstruction are more likely to quit smoking
Thorax, October 1, 2006; 61(10): 869 - 873.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
J. E. Henningfield, R. V. Fant, A. R. Buchhalter, and M. L. Stitzer
Pharmacotherapy for Nicotine Dependence
CA Cancer J Clin, September 1, 2005; 55(5): 281 - 299.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
W. H. Berrettini and C. E. Lerman
Pharmacotherapy and Pharmacogenetics of Nicotine Dependence
Am J Psychiatry, August 1, 2005; 162(8): 1441 - 1451.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Lerman, F. Patterson, and W. Berrettini
Treating Tobacco Dependence: State of the Science and New Directions
J. Clin. Oncol., January 10, 2005; 23(2): 311 - 323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
S. M. Hall, G. L. Humfleet, V. I. Reus, R. F. Munoz, and J. Cullen
Extended Nortriptyline and Psychological Treatment for Cigarette Smoking
Am J Psychiatry, November 1, 2004; 161(11): 2100 - 2107.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
J. D. Anczak and R. A. Nogler II
Tobacco Cessation in Primary Care: Maximizing Intervention Strategies
Clin. Med. Res., July 1, 2003; 1(3): 201 - 216.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. B Jessen, S. Toubro, and A. Astrup
Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men
Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1442 - 1447.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
I Campbell
Nicotine replacement therapy in smoking cessation
Thorax, June 1, 2003; 58(6): 464 - 465.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
V. Bellia, F. Pistelli, D. Giannini, N. Scichilone, F. Catalano, M. Spatafora, R. Hopps, L. Carrozzi, S. Baldacci, F. Di Pede, et al.
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients
Eur. Respir. J., May 1, 2003; 21(40_suppl): 21S - 27s.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. D. Hurt, J. E. Krook, I. T. Croghan, C. L. Loprinzi, J. A. Sloan, P. J. Novotny, C. G. Kardinal, J. A. Knost, M. T. Tirona, F. Addo, et al.
Nicotine Patch Therapy Based on Smoking Rate Followed by Bupropion for Prevention of Relapse to Smoking
J. Clin. Oncol., March 1, 2003; 21(5): 914 - 920.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. Bohadana, F. Nilsson, T. Rasmussen, and Y. Martinet
Nicotine Inhaler and Nicotine Patch as a Combination Therapy for Smoking Cessation: A Randomized, Double-blind, Placebo-Controlled Trial
Arch Intern Med, November 13, 2000; 160(20): 3128 - 3134.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
D. A. Scott, J. A. Stapleton, R. M. Palmer, R. F. Wilson, G. Sutherland, P. Y. Coward, G. Gustavsson, E. W. Odell, and R. N. Poston
Plasma Concentrations of Reputed Tumor-associated Soluble CD44 Isoforms (v5 and v6) in Smokers Are Dose Related and Decline on Smoking Cessation
Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1211 - 1214.
[Abstract] [Full Text]

Home page
 DTBHome page
Nicotine replacement to aid smoking cessation
DTB, July 1, 1999; 37(7): 52 - 54.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.